Literature DB >> 8621736

Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis.

U H Dietz1, L J Sandell.   

Abstract

Retinoic acid (RA) is known to play a role in various aspects of skeletal development in vivo, including morphogenesis, growth plate maturation, and apoptosis. In cell culture, RA treatment of chondrocytes suppresses the differentiated phenotype characterized by production of type II collagen and aggrecan. In an effort to discover molecules involved in regulation of the chondrocyte phenotype or related to developmental processes such as chondrogenesis, mRNAs from bovine chondrocytes cultured with and without RA were amplified by reverse transcription-polymerase chain reaction (PCR) and compared by differential display. PCR products whose expression was inhibited by RA treatment were cloned. One cDNA encodes a molecule we call cartilage-derived retinoic acid-sensitive protein (CD-RAP), and its properties are described here. The full-length bovine CD-RAP mRNA was cloned after amplification by the rapid amplification of cDNA ends procedure, and a part of the rat CD-RAP mRNA was amplified by reverse transcription-PCR using sequence-specific primers. The bovine CD-RAP mRNA contains an open reading frame of 130 amino acids. CD-RAP mRNA expression, as determined by Northern blot analysis and in situ hybridization, was present only in cartilage primordia and cartilage. The inhibition of CD-RAP mRNA expression by RA in vitro was time- and dose-dependent and was tested over concentrations from 10(-8) to 10(-6) M. Southern blot analysis of genomic DNA indicated that CD-RAP was encoded by a single copy gene and that no other genes were closely related. What appears to be the human homologue of CD-RAP was recently isolated and cloned from a melanoma cell line and shown to function as a growth inhibitory protein (Blesch, A., Boberhoff, A.-K., Apfel, R., Behl, C., Hessdoerfer, B., Schmitt, A., Jachimcza, P., Lottspeich, F., Buettner, R., and Bogdahn, U. (1994) Cancer Res. 54, 5695-5701). Neither CD-RAP nor this protein showed any homology to known proteins. We speculate that, in vivo, CD-RAP functions during cartilage development and maintenance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621736     DOI: 10.1074/jbc.271.6.3311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Pitfalls in immunohistochemistry--a recent example.

Authors:  Alexander Riechers; Anja Katrin Bosserhoff
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Identification of putative retinoic acid target genes downstream of mesenchymal Tbx1 during inner ear development.

Authors:  Dennis C Monks; Bernice E Morrow
Journal:  Dev Dyn       Date:  2012-02-01       Impact factor: 3.780

3.  The extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like fold.

Authors:  R Stoll; C Renner; M Zweckstetter; M Brüggert; D Ambrosius; S Palme; R A Engh; M Golob; I Breibach; R Buettner; W Voelter; T A Holak; A K Bosserhoff
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

4.  [Serum markers for melanoma].

Authors:  S Ugurel
Journal:  Hautarzt       Date:  2005-02       Impact factor: 0.751

5.  Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy.

Authors:  Claudine G James; C Thomas G Appleton; Veronica Ulici; T Michael Underhill; Frank Beier
Journal:  Mol Biol Cell       Date:  2005-08-31       Impact factor: 4.138

6.  Solution structure and dynamics of melanoma inhibitory activity protein.

Authors:  Julie C Lougheed; Peter J Domaille; Tracy M Handel
Journal:  J Biomol NMR       Date:  2002-03       Impact factor: 2.835

7.  Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas.

Authors:  V Wagner; J Rudi; H Näher; W Stremmel
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

8.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

Authors:  Sui Lin; Machiko Ikegami; Yan Xu; Anja-Katrin Bosserhoff; Alvin M Malkinson; John M Shannon
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

9.  Melanoma biomarkers: Vox clamantis in deserto (Review).

Authors:  Mays Al-Shaer; Divya Gollapudi; Chris Papageorgio
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

10.  Single doublecortin gene therapy significantly reduces glioma tumor volume.

Authors:  Manoranjan Santra; Xuguang Zheng; Cindi Roberts; Sutapa Santra; Mei Lu; Swayamprava Panda; Feng Jiang; Michael Chopp
Journal:  J Neurosci Res       Date:  2010-02-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.